Washington, D.C., May 29, 2025 – The ERISA Industry Committee (ERIC) today submitted several recommendations regarding health care and retirement benefits to the U.S. Department of the Treasury and the Internal Revenue Service (IRS). The letter follows an agency request for stakeholders to recommend items to be considered for the Department’s 2025-2026 Priority Guidance Plan.
Topic Archives:
The ERISA Industry Committee Urges Maryland to Revise Paid Family and Medical Leave Program Regulations
Washington, D.C., November 21, 2024 – The ERISA Industry Committee (“ERIC”) this week submitted public comments on proposed regulations contained in “COMAR 09.42.01-09.42.04” (“Proposed Rules”) issued by the Maryland Department of Labor Family and Medical Leave Insurance Division (“Division”).
The ERISA Industry Committee Urges Colorado to Reconsider New Mental Health Parity Rules
Washington, D.C., November 20, 2024 – The ERISA Industry Committee (“ERIC”) this week, submitted public comments on proposed regulations (Proposed Rules) from the Colorado Division of Insurance aimed at administering parity for mental health and substance use disorder benefits. ERIC’s public comments strongly urge Colorado regulators to reconsider the Proposed Rules, cautioning that if the state rules conflict with future changes to federal law, it could lead to future compliance conflicts and undermine how employers administer benefit plans.
The ERISA Industry Committee Calls for Improvements to Proposed Rules Implementing Maine Paid Family and Medical Leave Program
Washington, D.C., October 2, 2024 – The ERISA Industry Committee (“ERIC”) this week, submitted public comments on proposed regulations (Proposed Rules) from the Maine Department of Labor aimed at implementing the state-administered paid family and medical leave insurance program enacted last year. ERIC’s public comments focus on the need to streamline state program requirements, provide clarity to help employers comply, and protect employers’ ability to design and provide generous paid leave benefits.
The ERISA Industry Committee Applauds FDA Efforts to Make Biosimilars More Accessible
Washington, D.C., August 20, 2024 – The ERISA Industry Committee (ERIC) today praised draft guidance (Guidance) by the U.S. Food and Drug Administration (FDA) that will help increase competition in the prescription drug markets, boosting the availability of affordable biosimilar drugs.
The ERISA Industry Committee Praises U.S. Patent and Trademark Office Proposed Rule to Reform Patent Process, Improve Competition, and Make Prescription Drugs More Affordable
The ERISA Industry Committee (ERIC) today praised a proposed rule by the U.S. Patent and Trademark Office (USPTO) to increase competition in the prescription drug markets, boosting the availability of affordable biosimilar drugs by reforming patent policies. The new rule would crack down on “terminal disclaimers,” a strategy used by branded drug manufacturers to stave off competition for much longer than Congress intended.
The ERISA Industry Committee Urges the Texas AG to Recognize the Limits of Texas State Authority
Washington, D.C., June 18, 2024 – The ERISA Industry Committee (“ERIC”) yesterday submitted comments in response to a request for opinion sent to Texas Attorney General Ken Paxton by Senator Charles Schwertner regarding the applicability and enforceability of two Texas state laws, HB 1763 and HB 1919, to self-funded health benefit plans governed by the federal Employee Retirement Income Security Act of 1974 (“ERISA”).
The ERISA Industry Committee Asks Treasury and IRS for Benefits Guidance
Washington, D.C., May 30, 2024 – The ERISA Industry Committee (ERIC) today asked the U.S. Department of the Treasury (Treasury) and the Internal Revenue Service (IRS) for additional clarity regarding the regulations governing health care and retirement benefits. The submission responds to the agencies’ call for stakeholders to recommend topics for their 2024-2025 Priority Guidance Plan.
The ERISA Industry Committee Pushes for Final Improvements to New York PBM Proposed Rules
Washington, D.C., May 28, 2024 – The ERISA Industry Committee (“ERIC”) today submitted public comments in response to updated regulations contained in “Proposed Consolidated Rulemaking for Insurance Regulations 219, 222, 224, and 226-229” (“Proposed Rules”) issued by the New York Department of Financial Services (“Department”) which seeks to implement the state’s 2021 lawcovering pharmacy benefit managers (“PBMs”).
The ERISA Industry Committee Urges Indiana Department of Insurance to Act Immediately and Address Conflict with Federal Law
Washington, D.C., May 17, 2024 – The ERISA Industry Committee (ERIC) recently filed public comments on proposed regulations issued by the Indiana Department of Insurance. This proposed rule seeks to implement legislative changes to the state’s All Payer Claims Database (APCD). ERIC’s comments alerted the Department that the proposed rule violates the Employee Retirement Income Security Act (“ERISA”) and would likely trigger a lawsuit if advanced in its current form.